# Cross-over Study of Coronary Risk Factors With a Polypill

> **NCT05030818** · PHASE4 · RECRUITING · sponsor: **Fundación EPIC** · enrollment: 88 (estimated)

## Conditions studied

- Coronary Artery Disease

## Interventions

- **DRUG:** Polypill of acetylsalicylic acid, ramipril and atorvastatin
- **DRUG:** Drugs taken separately: acetylsalicylic acid, ramipril and atorvastatin

## Key facts

- **NCT ID:** NCT05030818
- **Lead sponsor:** Fundación EPIC
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-10-14
- **Primary completion:** 2026-03-30
- **Final completion:** 2026-04-30
- **Target enrollment:** 88 (ESTIMATED)
- **Last updated:** 2025-08-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05030818

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05030818, "Cross-over Study of Coronary Risk Factors With a Polypill". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT05030818. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*